IiSGM

L1: Endocarditis

L2: Endovascular catheters.

Axis 2: Pneumonia

L1: Ventilator-associated pneumonia (VAP).

L2: Severe non–ventilator-associated pneumonia

Axis 3. Infections in immunodepressed patients

L1: Influenza and its clinical impact.

L2: BK Virus

L3: Infections in transplant recipients

Axis 4. Mycobacterial infection

L 1: Clonal complexity of tuberculosis

L2: Molecular epidemiology of tuberculosis

L3: Development of new molecular diagnosis techniques

L4: Characterization of infectivity

L5: QuantiFERON line.

Axis 5. Bone and joint infection

L1: Infection of joint prostheses

Axis 6. Invasive nosocomial mycosis

L1: Optimization of the diagnosis of invasive aspergillosis

L2: Prevention of nosocomial aspergillosis through control of the quality of room air.

L3: Treatment of invasive aspergillosis.

L4: Technological development in the diagnosis of invasive candidiasis.

L5: Treatment of invasive candidiasis.

L6: Less common fungal pathogens.

L7: Antifungal stewardship

L8: Fungal infection: animal models

L9: Studies of virulence and biofilm production

L10: Molecular characterization study.

Axis 7. Patógenos y antimicrobianos e impacto clínico del laboratorio de Microbiología cinica

L1: Intestinal microbiota in severely ill patients.

L2: Clostridium difficile

L3: Staphylococcus aureus

L4: Multiresistant gram-negative rods

L5: Rapid diagnostic techniques in sepsis